Your browser doesn't support javascript.
loading
Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer: Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison.
Chowdhury, Simon; Oudard, Stephane; Uemura, Hiroji; Joniau, Steven; Dearden, Lindsay; Capone, Camille; Van Sanden, Suzy; Diels, Joris; Hadaschik, Boris A.
Afiliação
  • Chowdhury S; Department of Medical Oncology, Guy's, King's, and St. Thomas' Hospitals, London, UK. simon.chowdhury@gstt.nhs.uk.
  • Oudard S; Georges Pompidou Hospital, University of Paris, Paris, France.
  • Uemura H; Yokohama City University Medical Center, Yokohama, Japan.
  • Joniau S; University Hospitals Leuven, Leuven, Belgium.
  • Dearden L; Janssen Global Services, Raritan, NJ, USA.
  • Capone C; Janssen EMEA, Beerse, Belgium.
  • Van Sanden S; Janssen EMEA, Beerse, Belgium.
  • Diels J; Janssen EMEA, Beerse, Belgium.
  • Hadaschik BA; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Adv Ther ; 39(1): 518-531, 2022 01.
Article em En | MEDLINE | ID: mdl-34797506

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article